Gilead Sciences Inc
Priscilla Medina stands with her husband, Jason Sanchez, and her son in the Rego Park neighborhood of Queens in New York on Wednesday, April 7, 2021. If Medina had gotten COVID-19 a year earlier, she would have had no treatments proven safe and effective to try. But when the 30-year-old nurse arrived at a Long Island hospital in March 2021, so short of breath she could barely talk, doctors knew just what to do. They quickly arranged for her to get a novel drug that supplies virus-blocking antibodies, and “by the next day I was able to get up and move around,” she said. After two days, “I really started turning the corner. I was showering, eating, playing with my son.” (AP Photo/Marshall Ritzel)
COVID treatment has improved, but many wish for an easy pill

By Marilynn Marchione Apr. 26, 2021 10:24 AM EDT

FILE - In this Thursday Oct. 15, 2020 file photo, A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary. Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. The World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves survival or avoids the need for breathing machines. (Zsolt Czegledi/MTI via AP, File)
Health experts clash over use of certain drugs for COVID-19

By Marilynn Marchione Nov. 20, 2020 12:37 AM EST

FILE - In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States. On Thursday, Oct. 22, 2020, the U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization. The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days on average in a large study led by the U.S. National Institutes of Health. (Gilead Sciences via AP)
FDA approves first COVID-19 drug: antiviral remdesivir

By Marilynn Marchione Oct. 22, 2020 05:16 PM EDT

Rev. Mario Carminati touches a pictures of his nephew Christian Persico, at a cemetery in Casnigo, near Bergamo, Italy, Sunday, Sept. 27, 2020. As the world counts more than 1 million COVID victims, the quiet of everyday life and hum of industry has returned to Bergamo, which along with the surrounding Lombardy region was the onetime epicenter of the outbreak in Europe. But the memory of those dark winter days, and the monumental toll of dead they left behind, has remained with those who survived only to see the rest of the world fall victim, too. (AP Photo/Antonio Calanni)
The Latest: All AZ counties now OKed for partial reopenings

By The Associated Press Oct. 01, 2020 01:36 AM EDT

XBiotech, AstraZeneca rise; Churchill Downs, Gilead fall

Aug. 24, 2020 04:27 PM EDT
NEW YORK (AP) — Stocks that moved heavily or traded substantially Monday: XBiotech, Inc., up $1.21 to $19.57. The...

Boxes containing masks are loaded onto a South Korea Air Force cargo plane at the Gimhae airbase in Busan, South Korea, Friday, May 8, 2020. Military aircraft will be used to transport 500,000 masks intended for U.S. veterans of the 1950-53 Korean War as South Korea expands efforts to help other countries deal with the coronavirus while its own outbreak slows. (Son Hyung-joo/Yonhap via AP)
Asia Today: SKorea advises clubs to close, may delay schools

May. 07, 2020 10:21 PM EDT

Children wearing face masks stand on the steps of a scaled replica of the United States Capitol Building at the World Park in Beijing on Thursday, May 7, 2020. World tourism has been hard hit by the outbreak of the COVID-19 coronavirus as countries close borders and restricted international flights. (AP Photo/Ng Han Guan)
The Latest: Japan, U.S. agree to cooperate in COVID-19 fight

By The Associated Press May. 07, 2020 02:31 AM EDT